Document is current
Any future updates will be listed below
-
Authors
Lee, Seunghyun https://orcid.org/0000-0002-2251-0453
Ricci, Biancamaria
Tran, Jennifer https://orcid.org/0000-0001-5339-1218
Eul, Emily
Ye, Jiayu
Ren, Qihao https://orcid.org/0000-0001-5178-1829
Clever, David
Wang, Julia https://orcid.org/0000-0002-2233-8841
Wong, Pamela https://orcid.org/0000-0002-6856-2603
Haas, Michael S.
Stewart, Sheila A. https://orcid.org/0000-0002-2260-9576
Ma, Cynthia X. https://orcid.org/0000-0002-8156-7492
Fehniger, Todd A. https://orcid.org/0000-0002-8705-2887
Faccio, Roberta https://orcid.org/0000-0003-1639-2005
- License Information
-
More Information
Article History
Received: 1 April 2024
Accepted: 14 January 2025
First Online: 30 January 2025
Competing interests
: The DKK1-neutralizing antibody mDKN01 and relevant IgG control antibody were provided at no cost for this study by Leap Therapeutics. No financial support from Leap Therapeutics was provided to perform this study. M.H. is employed by Leap Therapeutics and owns company stocks. None of the other authors have competing interests in this work.
